UCLE's Losses Widen Amid Revenue Drop, Raising Going Concern Doubts

TL;DR

**UCLE is bleeding cash and revenue, making it a high-risk bet with a 'going concern' warning that screams 'stay away'.**

AI Summary

US NUCLEAR CORP. (UCLE) reported a net loss of $768,031 for the six months ended June 30, 2025, an increase from the $617,404 net loss in the same period of 2024. Revenue declined by 18.27% to $923,776 for the six months ended June 30, 2025, compared to $1,130,318 in the prior year. Gross profit also decreased to $598,249 from $612,210 year-over-year. Selling, general and administrative expenses rose significantly by 14.15% to $1,278,255 for the six months ended June 30, 2025, up from $1,119,839. The company's cash position significantly deteriorated, with cash decreasing from $130,840 at December 31, 2024, to $46,285 at June 30, 2025. Total current assets fell to $1,929,877 from $2,070,168, while total liabilities decreased from $3,503,012 to $3,256,538. The accumulated deficit grew to $20,560,940 as of June 30, 2025, from $19,676,325 at December 31, 2024, raising substantial doubt about its ability to continue as a going concern. Management plans to seek additional capital through private placement offerings of debt and equity securities to mitigate this risk.

Why It Matters

For investors, UCLE's widening net loss of $768,031 and declining revenue of $923,776 signal significant operational challenges and a precarious financial position. The 'going concern' warning, coupled with a shrinking cash balance of $46,285, indicates high risk and potential for further dilution through planned debt and equity offerings. Employees might face job insecurity if the company fails to secure additional financing or improve profitability. Customers could experience disruptions in product availability or support if the company's financial health deteriorates further, especially given its niche in radiation detection equipment. In a competitive market, UCLE's struggles could allow larger, more stable competitors to gain market share, impacting the broader industry landscape.

Risk Assessment

Risk Level: high — The company reported a net loss of $768,031 for the six months ended June 30, 2025, and an accumulated deficit of $20,560,940, which explicitly raises "substantial doubt about its ability to continue as a going concern." Cash decreased significantly from $130,840 to $46,285, representing a 64.6% decline in just six months, indicating severe liquidity issues.

Analyst Insight

Investors should avoid UCLE given the explicit 'going concern' warning, declining revenues, and increasing losses. The company's reliance on future private placements for survival suggests high dilution risk for existing shareholders. Monitor for successful capital raises and a clear path to profitability before considering any investment.

Financial Highlights

debt To Equity

N/A

revenue

$923,776

operating Margin

N/A

total Assets

$2,505,836

total Debt

$4,061,810

net Income

$-768,031

eps

$0.01

gross Margin

64.76%

cash Position

$46,285

revenue Growth

-18.27%

Key Numbers

• $768,031 — Net Loss (Increased from $617,404 in prior year, indicating worsening profitability.)
• $20,560,940 — Accumulated Deficit (Significant and growing, raising 'going concern' doubts.)
• $46,285 — Cash (Decreased by 64.6% from $130,840, highlighting severe liquidity issues.)
• $923,776 — Sales (Decreased by 18.27% from $1,130,318, showing declining revenue.)
• $1,278,255 — SG&A Expenses (Increased by 14.15% from $1,119,839, contributing to wider losses.)
• 60,077,263 — Common Shares Outstanding (As of October 23, 2025, indicating potential for further dilution.)
• $0.01 — Loss per Share (Consistent loss per share despite increased share count.)
• $1,929,877 — Total Current Assets (Decreased from $2,070,168, reflecting a weaker balance sheet.)
• $2,451,266 — Total Current Liabilities (Slightly decreased from $2,697,590, but still high relative to current assets.)
• $57,573 — Preferred Stock Dividends Payable (Non-cash disclosure, adding to financial obligations.)

Key Players & Entities

• US NUCLEAR CORP. (company) — registrant
• Electronic Control Concepts (company) — acquired subsidiary
• Overhoff Technology Corporation (company) — acquired subsidiary
• Optron Scientific Company (company) — wholly-owned subsidiary
• SEC (regulator) — Securities and Exchange Commission
• $768,031 (dollar_amount) — net loss for six months ended June 30, 2025
• $20,560,940 (dollar_amount) — accumulated deficit as of June 30, 2025
• $46,285 (dollar_amount) — cash balance as of June 30, 2025
• $923,776 (dollar_amount) — sales for six months ended June 30, 2025
• $1,278,255 (dollar_amount) — selling, general and administrative expenses for six months ended June 30, 2025

FAQ

Risk Factors

• Going Concern Uncertainty [high — financial]: The company recorded a net loss of $768,031 for the six months ended June 30, 2025, and has an accumulated deficit of $20,560,940 as of June 30, 2025. This raises substantial doubt about its ability to continue as a going concern. Management plans to seek additional capital through private placement offerings of debt and equity securities to mitigate this risk.
• Deteriorating Liquidity [high — financial]: Cash decreased significantly from $130,840 at December 31, 2024, to $46,285 at June 30, 2025, a 64.6% reduction. Total current assets also fell to $1,929,877 from $2,070,168, indicating severe liquidity issues.
• Declining Revenue and Gross Profit [medium — financial]: Revenue for the six months ended June 30, 2025, declined by 18.27% to $923,776 compared to $1,130,318 in the prior year. Gross profit also decreased to $598,249 from $612,210, impacting overall financial performance.
• Increasing Operating Expenses [medium — financial]: Selling, general and administrative expenses rose by 14.15% to $1,278,255 for the six months ended June 30, 2025, up from $1,119,839 in the prior year. This increase in expenses, coupled with declining revenue, contributes to wider net losses.
• Potential Share Dilution [medium — financial]: With 60,077,263 common shares outstanding as of October 23, 2025, and management's plans to seek additional capital through equity offerings, there is a significant risk of further dilution for existing shareholders.
• Mine Safety Disclosures [low — regulatory]: The filing mentions 'Mine Safety Disclosures' as a section, indicating potential regulatory scrutiny or reporting requirements related to mining operations, though specific details are not provided in the excerpt.

Industry Context

The nuclear industry is capital-intensive and subject to stringent regulatory oversight. Companies in this sector often face long development cycles, significant R&D costs, and evolving market demands for energy solutions. Competition can arise from established players, emerging technologies, and alternative energy sources.

Regulatory Implications

Companies in the nuclear sector are subject to extensive regulations from bodies like the Nuclear Regulatory Commission (NRC) in the US. Compliance with safety, security, and environmental standards is paramount and can involve significant costs and operational constraints. Changes in government policy or international agreements can also impact the industry.

What Investors Should Do

1. Monitor management's success in securing additional capital through private placements, as this is critical for addressing the going concern issue and potential dilution.
2. Analyze the drivers behind the 18.27% revenue decline and the 14.15% increase in SG&A expenses to understand the operational challenges.
3. Evaluate the company's ability to improve gross margins and control operating expenses to achieve profitability and alleviate the growing accumulated deficit.
4. Assess the long-term viability of US NUCLEAR CORP.'s business model given the persistent net losses and deteriorating cash position.

Key Dates

• 2025-06-30: Six months ended June 30, 2025 financial reporting period — Reveals a net loss of $768,031 and a significant decrease in cash, highlighting ongoing financial challenges.
• 2025-12-31: Year ended December 31, 2024 financial position — Provided a baseline for comparison, showing a cash position of $130,840 and an accumulated deficit of $19,676,325.
• 2025-10-23: Common Shares Outstanding — Reported 60,077,263 common shares outstanding, indicating potential for future dilution.

Glossary

Accumulated deficit

The total net losses of a company since its inception that have not been offset by net income. (A growing accumulated deficit, such as US NUCLEAR CORP.'s $20,560,940 as of June 30, 2025, indicates persistent unprofitability and raises concerns about the company's long-term viability.)

Going concern

An assumption that a company will continue to operate for the foreseeable future, typically at least 12 months. (Substantial doubt about US NUCLEAR CORP.'s ability to continue as a going concern, due to its net losses and accumulated deficit, means investors should be aware of potential bankruptcy risks.)

Private placement

The sale of securities to a select group of investors, rather than through a public offering. (US NUCLEAR CORP.'s plan to seek capital through private placements suggests a need for immediate funding and may lead to dilution for existing shareholders.)

Gross profit

The profit a company makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services. (A decrease in gross profit from $612,210 to $598,249 for US NUCLEAR CORP. indicates a potential issue with pricing, cost of goods sold, or sales volume.)

Selling, general and administrative expenses (SG&A)

The total costs of operating a business, excluding the cost of goods sold and other direct costs. (An increase in SG&A expenses for US NUCLEAR CORP. from $1,119,839 to $1,278,255, while revenue declines, exacerbates losses and signals potential inefficiencies.)

Year-Over-Year Comparison

Compared to the prior year's six-month period, US NUCLEAR CORP. experienced an 18.27% decrease in revenue, falling from $1,130,318 to $923,776. Gross profit saw a slight decline, while selling, general and administrative expenses increased by 14.15% to $1,278,255. This combination of lower sales and higher operating costs led to a wider net loss of $768,031, up from $617,404. The company's cash position has significantly worsened, and the accumulated deficit has grown, intensifying concerns about its ability to continue as a going concern.

Filing Documents

• ea0261448-10q_usnuclear.htm (10-Q) — 837KB
• ea026144801ex10-3_usnuclear.htm (EX-10.3) — 12KB
• ea026144801ex10-4_usnuclear.htm (EX-10.4) — 14KB
• ea026144801ex31-1_usnuclear.htm (EX-31.1) — 10KB
• ea026144801ex31-2_usnuclear.htm (EX-31.2) — 10KB
• ea026144801ex32-1_usnuclear.htm (EX-32.1) — 4KB
• ea026144801ex32-2_usnuclear.htm (EX-32.2) — 4KB
• image_001.jpg (GRAPHIC) — 11KB
• 0001213900-25-102663.txt ( ) — 6249KB
• ucle-20250630.xsd (EX-101.SCH) — 54KB
• ucle-20250630_cal.xml (EX-101.CAL) — 39KB
• ucle-20250630_def.xml (EX-101.DEF) — 296KB
• ucle-20250630_lab.xml (EX-101.LAB) — 522KB
• ucle-20250630_pre.xml (EX-101.PRE) — 311KB
• ea0261448-10q_usnuclear_htm.xml (XML) — 652KB

Risk Factors

Risk Factors 26 Item 2. Unregistered Sales of Equity Securities and Use of Proceeds 26 Item 3. Defaults Upon Senior Securities 27 Item 4. Mine Safety Disclosures 27 Item 5. Other Information 27 Item 6. Exhibits 27

- FINANCIAL INFORMATION

PART I - FINANCIAL INFORMATION

Financial Statements

Item 1. Financial Statements. US NUCLEAR CORP. AND SUBSIDIARIES CONDENSED CONSOLIDATED BALANCE SHEETS June 30, December 31, 2025 2024 (unaudited) (audited) ASSETS CURRENT ASSETS Cash $ 46,285 $ 130,840 Accounts receivable, net 38,533 351,398 Note receivable 40,916 41,916 Inventories 1,804,143 1,536,014 Prepaid expenses and other current assets - 10,000 TOTAL CURRENT ASSETS 1,929,877 2,070,168 Property and equipment, net 1,244 1,964 Investments 4,539 4,539 Goodwill 570,176 570,176 TOTAL ASSETS $ 2,505,836 $ 2,646,847 LIABILITIES AND SHAREHOLDERS' EQUITY CURRENT LIABILITIES Accounts payable $ 279,511 $ 256,276 Accrued liabilities 1,166,065 1,025,954 Accrued compensation – officers 13,000 13,000 Customer deposit 302,472 423,548 Notes payable 152,758 169,624 Convertible notes payable, net of debt discount - 405,403 Note payable to shareholder 126,512 92512 Line of credit 410,948 311,273 TOTAL CURRENT LIABILITIES 2,451,266 2,697,590 LONG-TERM LIABILITIES Notes payable 805,272 805,422 TOTAL LONG-TERM LIABILITIES 805,272 805,422 COMMITMENTS & CONTINGENCIES - - TOTAL LIABILITIES 3,256,538 3,503,012 SHAREHOLDERS' EQUITY: Common stock, $ 0.0001 par value; 100,000,000 shares authorized, 59,942,263 and 52,712,778 shares issued and outstanding 5,995 5,271 Common shares to be issued ( 572,660 shares) 247,386 45,813 Preferred stock, Series A, $ 0.0001 par value, 10,000 shares authorized, 2,006 and - 0 -, issued and outstanding 201 - Preferred shares, Series A to be issued - 2,006,000 Additional paid in capital 19,556,656 16,763,076 Accumulated deficit ( 20,560,940 ) ( 19,676,325 ) TOTAL SHAREHOLDERS' EQUITY ( 750,702 ) ( 856,165 ) TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY $ 2,505,836 $ 2,646,847 The accompanying notes are an integral part of these unaudited condensed consolidated financial statements. 1 US NUCLEAR CORP. AND SUBSIDI

financial statements

financial statements The unaudited interim financial statements included herein, presented in accordance with United States generally accepted accounting principles and Commission ("SEC"). Certain information and footnote disclosure normally included in financial statements prepared in accordance with generally accepted accounting principles have been condensed or omitted pursuant to such rules and regulations, although the Company believes that the disclosure is adequate to make the information presented not misleading. These statements reflect all adjustment, consisting of normal recurring adjustments, which, in the opinion of management, are necessary for fair presentation of the information contained therein. It is suggested that these interim financial statements be read in conjunction with the financial 10-K filed on June 25, 2025. The Company follows the same accounting policies in the preparation of interim reports. Results of operations for the interim period are not indicative of annual results. Going Concern The accompanying consolidated financial statements have been prepared assuming that the Company will continue as a going concern. The Company recorded a net loss of $ 768,031 for the six months ended June 30, 2025, and had an accumulated deficit of $ 20,560,940 as of June 30, 2025, which raises substantial doubt about its ability to continue as a going concern. The Company's ability to continue as a going concern is dependent upon its ability to generate profitable operations in the future and/or obtain the necessary financing to meet its obligations and repay its liabilities arising from normal business operations when they come due. Management has plans to seek additional c

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS FOR THE SIX MONTHS ENDED JUNE 30, 2025 and 2024 Cash and Cash Equivalents Cash and cash equivalents include cash on hand and cash in time deposits, certificates of deposit and all highly liquid debt instruments with original maturities of three months or less. There were no cash equivalents as of June 30, 2025, and December 31, 2024. Concentration of Credit Risk Financial instruments, which potentially subject the Company to concentrations of credit risk, consist of cash and cash equivalents. The Company places its cash with high quality financial institutions and at times may exceed the FDIC insurance limit. The Company has not and does not anticipate incurring any losses related to this credit risk. Accounts Receivable The Company maintains reserves for potential credit losses for accounts receivable. Management reviews the composition of accounts receivable and analyzes historical bad debts, customer concentrations, customer credit worthiness, current economic trends and changes in customer payment patterns to evaluate the adequacy of these reserves. Reserves are recorded based on the Company's historical collection history in addition to an analysis of future potential credit losses. Management considers the aging of accounts receivable, changes to customer credit ratings, as well as any industry-specific factors and economic growth trends that could impact credit loss estimates. Allowance for doubtful accounts as of June 30, 2025, and December 31, 2024 were $ 6,590 and $ 6,590 , respectively. Inventories Inventories are valued at the lower of cost (determined primarily by the average cost method) or net realizable value. Management compares the cost of inventories with the net realizable value and allowance is made for writing down their inventories to net realizable value, if lower. As of June 30, 2025, and December 31, 2024, the Company recorded $ 37,351 and $ 37,351 , respectively, in allowance for s

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS FOR THE SIX MONTHS ENDED JUNE 30, 2025 and 2024 Long-Lived Assets The Company applies the provisions of Accounting Standards Codification ("ASC") Topic 360, Property, Plant, and Equipment , which addresses financial accounting and reporting for the impairment or disposal of long-lived assets. ASC 360 requires impairment losses to be recorded on long-lived assets used in operations when indicators of impairment are present and the undiscounted cash flows estimated to be generated by those assets are less than the assets' carrying amounts. In that event, a loss is recognized based on the amount by which the carrying amount exceeds the fair value of the long-lived assets. Loss on long-lived assets to be disposed of is determined in a similar manner, except that fair values are reduced for the cost of disposal. Based on its review at June 30, 2025, and December 31, 2024, the Company believes there was no impairment of its long-lived assets. Goodwill Goodwill represents the excess of the purchase price over the underlying net assets of businesses acquired. The entire goodwill balance in the accompanying financial statements resulted from the Company's acquisition of Overhoff Technology Corporation in 2006. The Company complies with ASC 350, Goodwill and Other Indefinite Lived Intangible Assets , requiring that an impairment test be performed at least annually. As of June 30, 2025, and December 31, 2024, the Company performed the required impairment analysis, resulting in no impairment adjustments. Significant estimates used in the goodwill impairment analysis may change in the upcoming year if revenues do not rebound and the cost of materials continues to increase. Investments The Company accounts for investments in equity securities without a readily determinable fair value at cost, minus impairment. If the Company identifies observable price changes in orderly transactions for the identical or a similar investment

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS FOR THE SIX MONTHS ENDED JUNE 30, 2025 and 2024 The Company relied upon guidance and accounted for the Series A Convertible Preferred in accordance with ASC 480 and ASC 470 and determined that the Series A Preferred shares would be considered equity transactions. Except for the dividends, the only mandatory payments are the conversions at maturity, however since the conversions are settled in the Company's own common stock, the Series A Preferred do not meet the criteria for liability classification. The Company also considered the requirement to classify the Series A Convertible Preferred as temporary equity; however, the Series A shares are not redeemable at the holder's discretion. The Call option rests solely with management of the Company and the mandatory redemption does not necessitate cash payment since the Company has the option to settle in common stock. The Company considered it highly unlikely that it would redeem the shares for cash at maturity. In addition, extinguishment of debt transactions with related parties are considered to be capital transactions. Treasury Stock The company may, from time to time, re-acquire its own issued and outstanding common or preferred stock. Reacquired shares are designated as treasury shares and are recorded at the cost of the shares surrendered. Treasury shares are not considered an asset; rather, they are presented as a deduction from total stockholders' equity on the balance sheet. The company accounts for treasury share transactions using the Par Value Method in accordance with ASC 505-30. (See Note 9) Warrants The Company accounts for warrants as either equity-classified or liability-classified instruments based on an assessment of the warrant's specific terms and applicable authoritative guidance in Financial Accounting Standards Board ("FASB") Accounting Standards Codification ("ASC") 480, "Distinguishing Liabilities from Equity" ("ASC 480") and ASC 815, "Deri

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS FOR THE SIX MONTHS ENDED JUNE 30, 2025 and 2024 These five elements, as applied to each of the Company's revenue categories, are summarized below: Product sales - revenue is recognized when the Company performs its obligations under the contracts it has with its customers to deliver products at an agreed upon price and it is generally when the control of the produc

View Full Filing

View this 10-Q filing on SEC EDGAR